Lonvo-z is an in vivo CRISPR gene editing candidate that is designed to inactivate the kallikrein B1 gene, thereby permanently lowering kallikrein and bradykinin levels.

About one-third of children and adolescents use dietary supplements in the US, according to a study published online April 24 in Pediatrics Open Science. Brandy ...

Treatment with three low-dose agents in single pill linked to lower incidence of recurrent stroke, major cardiovascular events in patients with hemorrhagic stroke ...

Officials say the move conflicts with past promises to limit ties between the government and the tobacco industry.

Early signs include a high fever, cough, runny nose and red, watery eyes. A red rash that starts at the hairline usually appears three to five days later. People can spread the virus from 4 days ...

Intralesional nivolumab seems effective for reducing the size of precancerous oral lesions, according to a study presented at the annual meeting of the American Association for Cancer Research, held ...

The expanded approval was based on the single-arm, non-randomized, open-label phase 4 PETITE-T1D study, which evaluated the safety and pharmacokinetics of teplizumab.

Two-drug, single-tablet approved for HIV; Dupixent approved for pediatric CSU; novel treatment significantly improves ...

Amyloid-beta-targeted monoclonal antibodies probably resulted in little to no difference in cognitive function or in dementia severity.

Early myocarditis onset may predict treatment-related fatality in patients receiving immune checkpoint inhibitor therapy.

The expanded approval was based on data extrapolated from Study A, B, and C of the LIBERTY-CUPID program and supportive pharmacokinetics data from the single-arm CUPIDKids study.

Findings based on national survey of adults visiting an emergency department. HealthDay News — Substantial gaps in adult ...